Many New Frontiers Ahead For Regeneron

 
• By Jessica Merrill

Chief scientific officer George Yancopoulos talked to Scrip about the company’s plans to develop muscle-sparing weight loss drugs and Regeneron’s continued expansion into new areas.

Regeneron headquarters
Regeneron's Yancopoulos talked about development plans in an interview. • Source: Shutterstock

More from R&D

More from Scrip